Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiufeng Liu
Institutions:
Nanjing General Hospital of Nanjing Military Command,
Nanjing University,
Technical University of Denmark
Observed institutions:
Nanjing General Hospital of Nanjing Military Command,
81th Hospital of PLA,
Chinese People's Liberation Army,
Nanjing Medical University,
Nanjing University,
Technical University of Denmark
show all 6
ORCID:
0000-0002-2471-584X
Observed ORCID:
0000-0002-2471-584X
OpenAlex ID:
A5087022032
Pembrolizumab plus best supportive care versus placebo plus best supportive care as second-line therapy in patients in Asia with advanced hepatocellular carcinoma (HCC): Phase 3 KEYNOTE-394 study.
2022
·
Shukui Qin
, Zhendong Chen
, et al.
·
Journal of Clinical Oncology
·
122
A novel nomogram for predicting the prognosis of hepatocellular carcinoma patients following immune checkpoint inhibitors treatment beyond progression: a single center study based on Chinese population
2024
·
Chao Chen
, Xiaoyuan Chu
, et al.
·
HepatoBiliary Surgery and Nutrition
·
6
Metabolic characteristics and risk profile of non-obese fatty liver disease in an elderly Chinese community cohort
2026
·
Henghong Lin
, Zhijin Wang
, et al.
·
BMC Gastroenterology
·
3
Age-Adjusted Charlson Comorbidity Index Guides Risk Stratification for Hepatocellular Carcinoma Patients Treated with TACE Combined with Immune Checkpoint Inhibitors and Targeted Therapy: A Multicenter Retrospective Cohort Study
2026
·
Xiaohan Lin
, Shiying Zhang
, et al.
·
Liver Cancer
·
3
PDF
Prognostic analysis of systemic antitumor therapy in young patients with advanced liver cancer: A cohort study
2024
·
Jue Zhang
, Chao Chen
, et al.
·
Oncology Letters
·
3
PDF
Clinical Outcomes of AFP-Negative Patients with Advanced HCC: A Propensity-Matched Analysis from a Retrospective Cohort Study
2025
·
Xiufeng Liu
, Lijun Zhuang
, et al.
·
Journal of Hepatocellular Carcinoma
·
2
PDF
Real-world survival outcomes with ivosidenib in Chinese patients with IDH1-mutated intrahepatic cholangiocarcinoma.
2025
·
Chao Chen
, Ning Han
, et al.
·
Journal of Clinical Oncology
·
2
PDF
Novel models for predicting individualized outcomes in patients with advanced hepatocellular carcinoma receiving immunotherapy
2026
·
Chao Chen
, Yang Wang
, et al.
·
Frontiers in Oncology
·
1
PDF
Envafolimab (KN035) plus gemcitabine and oxaliplatin (GEMOX) compared with GEMOX as first-line treatment for Chinese patients with advanced biliary tract cancer: A randomized, open-label, multi-center, phase III pivotal trial.
2026
·
Shukui Qin
, Weijia Fang
, et al.
·
Journal of Clinical Oncology
·
1
TRIM21 promotes colorectal cancer malignancy by coupling USP4/TGF-β signaling to ferroptosis-related homeostasis
2026
·
Qian Wang
, Lin Yao
, et al.
·
Cytotechnology
·
1
Tumor necrosis, an independent prognostic factor for predicting gastric gastrointestinal stromal tumors
2025
·
Kunlong Chang
, Renjie Li
, et al.
·
Journal of Gastrointestinal Oncology
·
1
Hepatitis B virus gene integration affects the efficacy of systemic drug therapy after radical resection of liver cancer: A prospective cohort study
2023
·
Zixiong Li
, Chao Chen
, et al.
·
Research Square
Show more works
View as search
Works count:
12
Citation count:
145
H-index:
3
I10-index:
1
Year
Topic
Type